Breast cancer highlights from ESMO 2018

Bookmark and Share
Published: 12 Nov 2018
Views: 2327
Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium

Dr Lambertini speaks with ecancer at ESMO 2018 in Munich about the conference highlights in breast cancer research.

He discusses results from the PALOMA-3, SOLAR-1 and IMpassion trials, as well as the CANTO study on treatment adherence and the ShortHER study of abbreviated treatment.

For more conference highlights, Prof Gordon McVie discussed all the headline results of ESMO 2018.